Forecast & Rating3 analysts currently cover Obsidian Therapeutics, of which 3 give a positive rating. The average price target is $42.50, about 127.3% upside from the current price of $18.70. Coverage is limited, so the data is for reference only. Data as of Aug 19, 2026; this does not constitute investment advice.
Aug 18, 2026Price forecast
$42.50127.27%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 24, 2026
Forecast met0.0%
Stock price$18.70
Avg. target$42.5
High target$43
Low target$42
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.